vs
Side-by-side financial comparison of Brookfield Wealth Solutions Ltd. (BNT) and Edwards Lifesciences (EW). Click either name above to swap in a different company.
Brookfield Wealth Solutions Ltd. is the larger business by last-quarter revenue ($3.0B vs $1.6B, roughly 1.8× Edwards Lifesciences). Edwards Lifesciences runs the higher net margin — 23.1% vs 17.0%, a 6.1% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs 4.7%).
Brookfield Corporation is a Canadian multinational company that is one of the world's largest alternative investment management companies. It has over US$1 trillion of assets under management, much of which is workers’ deferred income from global public pension funds. It focuses on direct control investments in real estate, renewable power, infrastructure, credit and private equity. The company invests in distressed securities through Oaktree Capital, which it bought in 2019. Brookfield Corp...
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.
BNT vs EW — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.0B | $1.6B |
| Net Profit | $516.0M | $380.7M |
| Gross Margin | — | 78.0% |
| Operating Margin | 20.0% | 1.8% |
| Net Margin | 17.0% | 23.1% |
| Revenue YoY | 4.7% | 16.7% |
| Net Profit YoY | 91.8% | 6.8% |
| EPS (diluted) | — | $0.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.6B | ||
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | $3.0B | $1.5B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $2.9B | $1.4B |
| Q1 26 | — | $380.7M | ||
| Q4 25 | — | $91.2M | ||
| Q3 25 | — | $291.1M | ||
| Q2 25 | $516.0M | $333.2M | ||
| Q1 25 | — | $358.0M | ||
| Q4 24 | — | $385.6M | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | $269.0M | $366.3M |
| Q1 26 | — | 78.0% | ||
| Q4 25 | — | 78.1% | ||
| Q3 25 | — | 77.8% | ||
| Q2 25 | — | 77.5% | ||
| Q1 25 | — | 78.7% | ||
| Q4 24 | — | 78.9% | ||
| Q3 24 | — | 80.6% | ||
| Q2 24 | — | 79.9% |
| Q1 26 | — | 1.8% | ||
| Q4 25 | — | 9.6% | ||
| Q3 25 | — | 19.8% | ||
| Q2 25 | 20.0% | 26.8% | ||
| Q1 25 | — | 27.9% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 25.9% | ||
| Q2 24 | -1.0% | 26.8% |
| Q1 26 | — | 23.1% | ||
| Q4 25 | — | 5.8% | ||
| Q3 25 | — | 18.7% | ||
| Q2 25 | 17.0% | 21.7% | ||
| Q1 25 | — | 25.3% | ||
| Q4 24 | — | 27.8% | ||
| Q3 24 | — | 226.7% | ||
| Q2 24 | 9.3% | 26.7% |
| Q1 26 | — | $0.66 | ||
| Q4 25 | — | $0.16 | ||
| Q3 25 | — | $0.50 | ||
| Q2 25 | — | $0.56 | ||
| Q1 25 | — | $0.61 | ||
| Q4 24 | — | $0.65 | ||
| Q3 24 | — | $5.13 | ||
| Q2 24 | — | $0.61 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $17.5B | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.8B | — |
| Total Assets | $148.9B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $4.2B | ||
| Q3 25 | — | $3.8B | ||
| Q2 25 | $17.5B | $4.1B | ||
| Q1 25 | — | $3.9B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | — | $4.4B | ||
| Q2 24 | $17.2B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | $10.3B | ||
| Q3 25 | — | $10.2B | ||
| Q2 25 | $15.8B | $10.5B | ||
| Q1 25 | — | $10.1B | ||
| Q4 24 | — | $10.0B | ||
| Q3 24 | — | $9.5B | ||
| Q2 24 | $9.0B | $7.4B |
| Q1 26 | — | — | ||
| Q4 25 | — | $13.7B | ||
| Q3 25 | — | $13.3B | ||
| Q2 25 | $148.9B | $13.5B | ||
| Q1 25 | — | $13.0B | ||
| Q4 24 | — | $13.1B | ||
| Q3 24 | — | $13.0B | ||
| Q2 24 | $130.5B | $10.1B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
